Join Renaissance's director of investment strategies for the Weekly Weigh-in. In this edition, Avery discusses the potential meaning of Anthropic's IPO delay. To stay on top of the IPO market, make sure to sign up for our weekly newsletter.
Join Renaissance's director of investment strategies for the Weekly Weigh-in. In this edition, Avery discusses what to look for when Anthropic files for its IPO. To stay on top of the IPO market, make sure to sign up for our weekly newsletter.
IPO Weekly Weigh-in: What Anthropic’s IPO delay means
Join Renaissance's director of investment strategies for the Weekly Weigh-in. In this edition, Avery discusses the potential meaning of Anthropic's IPO delay. To stay on top of the IPO market, make sure to sign up for our weekly newsletter.
...read more
IPO Weekly Weigh-in: 7 things to Ctrl+F when Anthropic files for an IPO
Join Renaissance's director of investment strategies for the Weekly Weigh-in. In this edition, Avery discusses what to look for when Anthropic files for its IPO. To stay on top of the IPO market, make sure to sign up for our weekly newsletter.
...read more
IPO Winners & Losers: New Stocks Surge, Biotech Booms, and AI Rallies
Welcome back to Renaissance Capital’s IPO Winners and Losers, the weekly podcast breaking down the biggest stories shaping the IPO market. Click here to get the newsletter in your inbox every week.
...read moreIPO Winners & Losers: Biotech Soars, Jersey Mike's Misses, and SpaceX Faces the Lockup
Welcome back to Renaissance Capital’s IPO Winners and Losers, the weekly podcast breaking down the biggest stories shaping the IPO market. Click here to get the newsletter in your inbox every week.
...read more